GLP-1R receptor agonist compound and use thereof
US11773087B2 · kind B2 · utility
0Cited by
0References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 30, 2023 |
| Grant date | Oct 3, 2023 |
| Priority date | — |
| Expiry date | Mar 30, 2043 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/05
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a GLP-1R receptor agonist compound and a use thereof. Specifically, the present invention discloses a compound represented by formula (I) or a pharmaceutically acceptable salt thereof. The compound can be used for treating a metabolism-related disease, such as diabetes or nonalcoholic fatty liver disease, by means of activating GLP-1R receptors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.